They might reduce the proliferation of colon cancer cells by binding to TNF-α, down-regulating TNF-α, inhibiting the NF-κB signaling pathway, suppressing the CPG island from being in a hypermethylated state, and affecting the binding of proteins to the DNA promoter region. The gene discussed is NFKB1; the disease is malignant colon neoplasm.